Integra Lifesciences Holdings Corp (IART) — 8-K Filings

8-K Filings (8)

• 8-K Filing — May 5, 2026
• Integra LifeSciences Announces Executive and Board Changes — Dec 12, 2025 Risk: medium
  Integra LifeSciences Holdings Corp. announced on December 11, 2025, changes in its executive team and board of directors. The filing details the departure of ce
• Integra LifeSciences Enters Material Definitive Agreement — Jun 9, 2025 Risk: medium
  Integra LifeSciences Holdings Corp. entered into a material definitive agreement on June 6, 2025, related to a direct financial obligation. The company, incorpo
• NovoCure to Acquire Integra LifeSciences for $1B — May 13, 2025 Risk: medium
  Integra LifeSciences Holdings Corp. announced on May 9, 2025, that it has entered into a definitive agreement to be acquired by an affiliate of NovoCure Limited
• Integra LifeSciences to be Acquired by Permira for $5.5B — Jan 6, 2025 Risk: medium
  Integra LifeSciences Holdings Corp. announced on December 19, 2024, that it has entered into a definitive agreement to be acquired by an affiliate of the privat
• Integra LifeSciences Appoints New CFO, Elects Directors — Dec 17, 2024 Risk: medium
  Integra LifeSciences Holdings Corp. announced on December 12, 2024, the appointment of Michael McBreen as Chief Financial Officer, effective immediately. McBree
• Integra LifeSciences Sells Cadence Science for $30M — May 17, 2024 Risk: low
  Integra LifeSciences Holdings Corp. announced on May 16, 2024, that it has entered into a definitive agreement to sell its Cadence Science business to an affili
• Integra LifeSciences to Acquire Acclarent for $271M — May 13, 2024 Risk: medium
  Integra LifeSciences Holdings Corp. announced on May 9, 2024, that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon Inc., a su

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX